1. Home
  2. EDUC vs XCUR Comparison

EDUC vs XCUR Comparison

Compare EDUC & XCUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Educational Development Corporation

EDUC

Educational Development Corporation

HOLD

Current Price

$1.42

Market Cap

13.1M

ML Signal

HOLD

XCUR

Exicure Inc.

HOLD

Current Price

$1.36

Market Cap

13.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EDUC
XCUR
Founded
1965
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Consumer Specialties
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
13.1M
13.7M
IPO Year
1995
2017

Fundamental Metrics

Financial Performance
Metric
EDUC
XCUR
Price
$1.42
$1.36
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
270.1K
233.4K
Earning Date
05-19-2026
03-25-2026
Dividend Yield
N/A
N/A
EPS Growth
142.86
83.37
EPS
N/A
N/A
Revenue
$22,913,600.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.01
$1.27
52 Week High
$1.84
$9.48

Technical Indicators

Market Signals
Indicator
EDUC
XCUR
Relative Strength Index (RSI) 36.51 29.43
Support Level $1.31 N/A
Resistance Level $1.49 $2.02
Average True Range (ATR) 0.05 0.15
MACD -0.00 -0.00
Stochastic Oscillator 35.71 12.01

Price Performance

Historical Comparison
EDUC
XCUR

About EDUC Educational Development Corporation

Educational Development Corp distributes books and educational products and publications through its PaperPie and EDC Publishing divisions to individual consumers, book, toy and gift stores, libraries and home educators located throughout the United States. The company is the owner and exclusive publisher of Kane Miller children's books; Learning Wrap-Ups, maker of educational manipulatives; and SmartLab Toys, maker of STEAM-based toys and games. It also the exclusive United States Multi-Level Marketing (MLM) distributor of Usborne Publishing Limited (Usborne) children's books. It sell children's books, educational toys and games and other related products. It has two reportable segments: PaperPie and Publishing of which majority of revenue comes from Paperpie.

About XCUR Exicure Inc.

Exicure Inc is a clinical-stage biotechnology company focused on developing treatments for blood-related diseases, with an emphasis on small-molecule therapies that have the potential to benefit a broad range of patients. The company acquired GPCR Therapeutics USA and secured a license for GPC-100 (Burixafor), a clinical-stage small-molecule compound that inhibits the chemokine receptor CXCR4. GPC-100 has demonstrated the ability to effectively mobilize various cell types, including hematopoietic stem cells and lymphocytes, highlighting its broad therapeutic potential across multiple indications.

Share on Social Networks: